FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
Go back to FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 49.12 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $49.12 | 52 Week High | $35.13 | |||
| Open | $49.12 | 52 Week Low | $28.10 | |||
| Day High | $49.12 | P/E | N/A | |||
| Day Low | $49.12 | EPS | $0.00 | |||
| Volume | 1,305 | |||||
| Brown & Brown, Inc. (NYSE: RO) | Delayed: 8.49 +0.55 (6.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.94 | 52 Week High | $8.59 | |||
| Open | $7.94 | 52 Week Low | $7.82 | |||
| Day High | $8.59 | P/E | 6.53 | |||
| Day Low | $7.82 | EPS | $1.30 | |||
| Volume | 42,732 | |||||
| Roper Industries (NASDAQ: ROP) | Delayed: 325.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $325.09 | 52 Week High | $195.93 | |||
| Open | $325.09 | 52 Week Low | $155.79 | |||
| Day High | $325.09 | P/E | 60.54 | |||
| Day Low | $325.09 | EPS | $5.37 | |||
| Volume | 1,118 | |||||
